George Gauthier - Nov 29, 2023 Form 4 Insider Report for IGM Biosciences, Inc. (IGMS)

Role
Chief Commercial Officer
Signature
/s/ Misbah Tahir, by power of attorney
Stock symbol
IGMS
Transactions as of
Nov 29, 2023
Transactions value $
$1,403
Form type
4
Date filed
12/1/2023, 07:02 PM
Previous filing
Oct 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IGMS Common Stock Award $8.73K +1.74K +4.45% $5.02 40.8K Nov 15, 2023 Direct F1
transaction IGMS Common Stock Sale -$7.33K -1.18K -2.89% $6.21 39.6K Nov 29, 2023 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were acquired under the IGM Biosciences, Inc. 2019 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
F2 These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
F3 This transaction was executed in multiple trades at prices ranging from $5.79 to $6.45. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.